Companies: 10,795·Total market cap: $144.5T
LadRx Corporation

LadRx Corporation

LADXOTCHealthcare● Active
$0.11
+$0.10(+872.73%)
Market Cap$52975
P/E Ratio—
52W High$2.4
52W Low$0.01
Overview

LadRx Corporation (LADX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0000799698 · LADX · OTC · as of Jun 9, 2026

Filing snapshot

1,000+
Total Filings
8-K
Latest Form
2025-07-31
Most Recent
1989
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0000799698 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2025-03-28
Fiscal Year End
Mar 28, 2025
Accession No.
0001641172-25-001038
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0000799698 · Accession 0001641172-25-001038

Latest Key Filings

10-QQuarterly Report
10-Q
2025-05-14
View 10-Q on SEC
8-KCurrent Report
8-K
2025-07-31Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2025-07-31
View
8-KCurrent Report
8-K
2025-06-27
View
10-QQuarterly Report
10-Q
2025-05-14
View
8-KCurrent Report
Current Report
2025-04-16
View
10-KAnnual Report
Annual Report
2025-03-28
View
SEC STAFF ACTIONSEC STAFF ACTION
SEC STAFF ACTION
2025-02-21
View
10-QQuarterly Report
Quarterly Report
2024-11-14
View
8-KCurrent Report
Current Report
2024-10-09
View
DEFA14AProxy Statement (Additional)
Proxy Statement (Additional)
2024-08-20
View
DEF 14AProxy Statement
Proxy Statement
2024-08-20
View
10-QQuarterly Report
Quarterly Report
2024-08-14
View
8-KCurrent Report
Current Report
2024-06-06
View
10-QQuarterly Report
Quarterly Report
2024-05-15
View
10-KAnnual Report
Annual Report
2024-03-27
View
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2024-02-14
View
Showing 1–15 of 774 filingsForm 4 / 144 hidden· 1000 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0000799698  |  Exchange: OTC · Healthcare

LadRx Corporation (OTC: LADX) has submitted 1,000+ documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1989. As a Healthcare sector company with CIK 0000799698, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is LadRx Corporation's most comprehensive regulatory disclosure. The most recent LadRx Corporation 10-K was filed on 2025-03-28 for fiscal year ending 2025. Historical LADX 10-K annual reports are available from 1997 through 2025.

Investors researching LadRx Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
ACBM SEC Filings →NSPDF SEC Filings →USRM SEC Filings →BIOIF SEC Filings →MRPI SEC Filings →INSD SEC Filings →NNBP SEC Filings →DNAG SEC Filings →
→ LADX Financials→ LADX Earnings→ LADX Insider Trades

Frequently Asked Questions

LADX SEC Filings · 8 questions

LadRx Corporation (LADX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 1,000+ filings and access original documents at no cost. LadRx Corporation's CIK is 0000799698.

LADX SEC filingsLadRx Corporation SEC documentsfind LADX 10-K